Validation of UV Spectrophotometric Method for Quantitative Determination of Entacapone in Tablets Using Experimental Design of Plackett‐Burman for Robustness Evaluation and Comparison with HPLC

References

• Bernheimer , H. , Birkmayer , W. , Hornykeiwicz , O. , Jellinger , K. and Seitelberger , F. 1973 . Brain dopamine and the syndrome of Parkinson and Huntington: Clinical morphological and neurochemical correlations . J. Neurol. Sci. , 20 : 415 – 455 .
   PubMed Web of Science ®Google Scholar
• Holm , K. and Spencer , C. 1999 . A review of its use in Parkinson's disease . Drugs , 58 : 159 – 177 .
   PubMed Web of Science ®Google Scholar
• 2005 . International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use . 2005 . ICH
   Google Scholar
• Keski‐Hynnilä , H. , Andersin , R. , Luukkanen , L. , Taskinen , J. and Kostiainen , R. 1998 . Analysis of catechol‐type glucuronides in urine samples by liquid chromatography‐electrospray ionization–tandem mass spectrometry . J. Chromatogr. A , 794 : 75 – 83 .
   Google Scholar
• Keski‐Hynnilä , H. , Raanaa , K. , Taskinen , J. and Kostiainen , R. 2000 . Direct analysis of nitrocatechol‐type glucuronides in urine by capillary electrophoresis‐eletrospray ionization mass spectrometry and tandem mass spectrometry . J. Chromatogr. B , 749 : 253 – 263 .
   PubMedGoogle Scholar
• Keski‐Hynnilä , H. , Raanaa , K. , Forsberg , M. , Männistö , P. , Taskinen , J. and Kostiainen , R. 2001 . Quantification of entacapone glucuronide in rat plasma by on‐line coupled restricted access media column and liquid chromatography‐tandem mass spectrometry . J. Chromatogr. B , 759 : 227 – 236 .
   PubMedGoogle Scholar
• Moffat , A. , Osselton , M. and Widdor , B. 2004 . Clarke's Analysis of Drugs and Poisons , 3rd Edn. Vol. 2 , 77 – 978 . Chicago : Pharmaceutical Press .
   Google Scholar
• Myllilä , T. , Haapaniemi , T. , Kaakkola , S. , Kinnunen , E. , Hartikainen , P. , Nuutinn , J. , Rissanen , A. , Kuopio , A. M. , Jolma , T. , Satomaa , O. and Heikkinen , H. 2006 . Patient satisfaction with switching to Stalevo: An open‐label evaluation in PD patients experiencing wearing‐off (Simcom Study) . Acta Neurol. Scand. , 114 : 181 – 186 .
   PubMedGoogle Scholar
• Paim , C. , Gonçalves , H. , Miron , D. , Sippel , J. and Steppe , M. 2007 . Stability‐indication LC determination of entacapone in tablets . Chromatographia , 65 : 595 – 599 .
   Google Scholar
• Rajeswari , K. , Sankar , G. , Rao , A. and Rao , J. 2006 . A new spectrophotometric method for the determination of entacapone in pure and tablet dosage form . Int. J. of Chem. Sci. , 4 ( 3 ) : 694 – 696 .
   Google Scholar
• Rajput , A. H. , Fenton , M. E. , Birdi , S. , Macaulay , R. , George , D. , Rozdilsky , B. , Ang , L. C. , Senthilselvan , A. and Hornykiewicz , O. 2002 . Clinical‐pathological study of levodopa complications . Mov. Disord. , 17 : 289 – 296 .
   PubMed Web of Science ®Google Scholar
• Ramakrishna , N. , Vishwottam , K. , Wishu , S. , Koteshwara , M. and Chidambara , J. 2005 . High‐performance liquid chromatography method for the quantification of entacapone in human plasma . J. Chromatogr. B , 823 : 189 – 194 .
   PubMedGoogle Scholar
• Snyder , L. , Kirkland , J. and Glajch , J. 1997 . “ Completing the method: Validation and transfer ” . In Practical HPLC Method Development , 2 685 – 713 . Hoboken : John Wiley & Sons .
   Google Scholar
• 2001 . The Merck Index, an Encyclopedia of Chemicals, Drugs, and Biologicals Whitehouse Station, NJ : Merck & Co . The Merck
   Google Scholar
• 2007 . The United States Pharmacopeia , 30 Rockville : United States Pharmacopeial Convention . USP 30
   Google Scholar
• Vander Heyden , Y. , Nijhuis , A. , Smeyers‐Verbeke , J. , Vandeginste , B. and Massat , D. 2001 . Guidance for robustness/ruggedness test in method validation . J. Pharm. Biomed. Anal. , 24 : 723 – 753 .
   PubMed Web of Science ®Google Scholar
• Watson , G. D. 2005 . “ Infrared spectrophotometry ” . In Pharmaceutical Analysis: A Textbook for Pharmacy Students and Pharmaceutical Chemists , 2nd Edn. 97 – 116 . London : Churchill Livingstone .
   Google Scholar
• Wikberg , T. , Vuorela , A. , Ottoila , P. and Taskinen , J. 1993 . Identification of major metabolites of the catechol‐O‐methyltransferase inhibitor entacapone in rats and humans . Drug. Metab. Dispos. , 21 : 81 – 91 .
   PubMed Web of Science ®Google Scholar